Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Toi, Masakazu"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-100 z 1000
Tytuł:
Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis
Autorzy:
Yamaguchi, Ayane
Kawaguchi, KosukeAff1, IDs1054902307163z_cor2
Kawanishi, Kana
Maeshima, Yurina
Nakakura, Akiyoshi
Kataoka, Tatsuki R.
Takahara, Sachiko
Nakagawa, Shunsaku
Yonezawa, Atsushi
Takada, Masahiro
Kawashima, Masahiro
Kawaguchi-Sakita, Nobuko
Kotake, Takeshi
Suzuki, Eiji
Shimizu, Hanako
Torii, Masae
Morita, Satoshi
Ishiguro, Hiroshi
Toi, Masakazu
Pokaż więcej
Źródło:
Breast Cancer Research and Treatment. 204(2):261-275
Czasopismo naukowe
Szczegóły
Tytuł:
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines
Autorzy:
Hattori, Masaya
Honma, Naoko
Nagai, Shigenori
Narui, Kazutaka
Shigechi, Tomoko
Ozaki, Yukinori
Yoshida, Masayuki
Sakatani, Takashi
Sasaki, Eiichi
Tanabe, Yuko
Tsurutani, Junji
Takano, Toshimi
Saji, Shigehira
Masuda, Shinobu
Horii, Rie
Tsuda, Hitoshi
Yamaguchi, Rin
Toyama, Tatsuya
Yamauchi, Chikako
Toi, Masakazu
Yamamoto, YutakaAff21, IDs12282024015500_cor21
Pokaż więcej
Źródło:
Breast Cancer. :1-5
Czasopismo naukowe
Szczegóły
Tytuł:
Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-Breast Cancer Registry
Autorzy:
Iwamoto, TakayukiAff1, IDs1228202401545x_cor1
Kumamaru, Hiraku
Niikura, Naoki
Sagara, Yasuaki
Miyashita, Minoru
Konishi, Takaaki
Sanuki, Naoko
Tanakura, Kenta
Nagahashi, Masayuki
Hayashi, Naoki
Yoshida, Masayuki
Watanabe, Chie
Kinukawa, Naoko
Toi, Masakazu
Saji, Shigehira
Pokaż więcej
Źródło:
Breast Cancer. 31(2):185-194
Czasopismo naukowe
Szczegóły
Tytuł:
2020 Annual Report of National Clinical Database-Breast Cancer Registry: 10-year mortality of elderly breast cancer patients in Japan
Autorzy:
Sagara, YasuakiAff1, Aff3, IDs12282023015328_cor1
Kumamaru, Hiraku
Niikura, Naoki
Miyashita, Minoru
Konishi, Takaaki
Iwamoto, Takayuki
Sanuki, Naoko
Tanakura, Kenta
Nagahashi, Masayuki
Hayashi, Naoki
Yoshida, Masayuki
Kinukawa, Naoko
Watanabe, Chie
Toi, Masakazu
Saji, Shigehira
Pokaż więcej
Źródło:
Breast Cancer. 31(2):179-184
Czasopismo naukowe
Szczegóły
Tytuł:
Medical care costs according to the stage and subtype of breast cancer in a municipal setting: a case study of Hachioji City, Japan
Autorzy:
Nishikawa, YoshitakaAff1, IDs12282023015177_cor1
Agatsuma, Nobukazu
Utsumi, Takahiro
Funakoshi, Taro
Mori, Yukiko
Nakamura, Yuki
Hoshino, NobuakiAff5, Aff6
Horimatsu, Takahiro
Saito, Takumi
Kashihara, Soichiro
Fukuyoshi, Jun
Goto, Rei
Toi, MasakazuAff4, Aff9
Takahashi, Yoshimitsu
Nakayama, Takeo
Pokaż więcej
Źródło:
Breast Cancer. 31(1):105-115
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of the coronavirus disease 2019 pandemic on 20 representative surgical procedures in Japan based on the National Clinical Database: annual surveillance of 2021 by the Japan Surgical Society
Autorzy:
Hibi, TaizoAff1, Aff2, IDs00595023027867_cor1
Yamamoto, Hiroyuki
Miyoshi, Takahiro
Ikeda, NorihikoAff1, Aff4, Aff5
Taketomi, AkinobuAff1, Aff6
Ono, MinoruAff1, Aff7
Toi, Masakazu
Hara, Hisato
Nagano, HiroakiAff1, Aff10
Kitagawa, YukoAff1, Aff11
Mori, MasakiAff1, Aff12
Pokaż więcej
Źródło:
Surgery Today: Official Journal of the Japan Surgical Society. :1-12
Czasopismo naukowe
Szczegóły
Tytuł:
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer
Autorzy:
Takada, Masahiro
Imoto, Shigeru
Ishida, Takanori
Ito, Yoshinori
Iwata, Hiroji
Masuda, Norikazu
Mukai, Hirofumi
Saji, Shigehira
Ikeda, Takafumi
Haga, Hironori
Saeki, Toshiaki
Aogi, Kenjiro
Sugie, Tomoharu
Ueno, Takayuki
Ohno, Shinji
Ishiguro, Hiroshi
Kanbayashi, Chizuko
Miyamoto, Takeshi
Hagiwara, Yasuhiro
Toi, MasakazuAff1, Aff16, IDs10549023070994_cor20
Pokaż więcej
Źródło:
Breast Cancer Research and Treatment. 202(3):485-496
Czasopismo naukowe
Szczegóły
Tytuł:
A multiparametric approach to predict triple-negative breast cancer including parameters derived from ultrafast dynamic contrast-enhanced MRI
Autorzy:
Ohashi, AkaneAff1, Aff2, Aff3
Kataoka, MasakoAff3, IDs0033002309730w_cor2
Iima, MamiAff3, Aff4
Honda, MayaAff3, Aff5
Ota, Rie
Urushibata, Yuta
Dominik Nickel, Marcel
Toi, Masakazu
Zackrisson, SophiaAff1, Aff2
Nakamoto, Yuji
Pokaż więcej
Źródło:
European Radiology. 33(11):8132-8141
Czasopismo naukowe
Szczegóły
Tytuł:
The degree of satisfaction and level of learning in male and female surgical residents: a nationwide questionnaire survey of graduating residents in Japan
Autorzy:
Hida, KoyaAff1, IDs0059502302683z_cor1
Hirano, Satoshi
Poudel, Saseem
Kurashima, Yo
Stefanidis, Dimitrios
Hashimoto, Daisuke
Akiyama, Hirotoshi
Eguchi, Susumu
Fukui, Toshihiro
Hagiwara, Masaru
Izaki, Tomoko
Kawamoto, Shunsuke
Otomo, Yasuhiro
Nagai, Eishi
Takami, Hideki
Takeda, Yuko
Toi, Masakazu
Yamaue, Hiroki
Yoshida, Motofumi
Yoshida, Shigetoshi
Kodera, Yasuhiro
Saito, Mitsue
Pokaż więcej
Źródło:
Surgery Today: Official Journal of the Japan Surgical Society. 53(11):1275-1285
Czasopismo naukowe
Szczegóły
Tytuł:
Comparison of osteoanabolic agents (teriparatide and romosozumab) with bisphosphonates in prevention of subsequent vertebral fractures in patients treated for osteoporotic vertebral fracture for 12 months: An observational cohort study
Autorzy:
Maruo, Keishi
Kusukawa, Tomoyuki
Toi, Masakazu
Yamaura, Tetsuto
Hatano, Masaru
Oishi, Hayato
Nagao, Kazuma
Arizumi, Fumihiro
Kishima, Kazuya
Yoshie, Norichika
Tachibana, Toshiya
Pokaż więcej
Źródło:
In Bone Reports June 2024 21
Czasopismo naukowe
Szczegóły
Tytuł:
Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study
Autorzy:
García-Sáenz, José Angel
Marmé, Frederik
Untch, Michael
Bonnefoi, Hervé
Kim, Sung-Bae
Bear, Harry
Mc Carthy, Nicole
Gelmon, Karen
Martin, Miguel
Kelly, Catherine M.
Reimer, Toralf
Toi, Masakazu
Law, Ernest
Bhattacharyya, Helen
Gnant, Michael
Makris, Andreas
Seiler, Sabine
Burchardi, Nicole
Nekljudova, Valentina
Loibl, Sibylle
Rugo, Hope S.
Pokaż więcej
Źródło:
In European Journal of Cancer January 2024 196
Czasopismo naukowe
Szczegóły
Tytuł:
Phase II trial of biweekly administration with eribulin after three cycles of induction therapy in hormone receptor-positive, HER2-negative metastatic breast cancer (JACCRO BC-03)
Autorzy:
Kobayashi, KokoroAff1, IDs1054902307030x_cor1
Masuda, NorikazuAff2, Aff3
Mizuno, Toshiro
Miura, Kayo
Tokuda, Yutaka
Yoshinami, Tetsuhiro
Kawaguchi, Hidetoshi
Ohtani, Shoichiro
Saeki, Toshiaki
Toi, Masakazu
Takeuchi, Masahiro
Ito, Yoshinori
Pokaż więcej
Źródło:
Breast Cancer Research and Treatment. 201(3):409-415
Czasopismo naukowe
Szczegóły
Tytuł:
Performance of dedicated breast PET in breast cancer screening: comparison with digital mammography plus digital breast tomosynthesis and ultrasound
Autorzy:
Yuge, Shunsuke
Miyake, Kanae K.Aff2, IDs12149023018469_cor2
Ishimori, Takayoshi
Kataoka, Masako
Matsumoto, YoshiakiAff3, Aff4
Torii, Masae
Yakami, Masahiro
Isoda, Hiroyoshi
Takakura, Kyoko
Morita, Satoshi
Takada, Masahiro
Toi, Masakazu
Nakamoto, Yuji
Pokaż więcej
Źródło:
Annals of Nuclear Medicine. 37(9):479-493
Czasopismo naukowe
Szczegóły
Tytuł:
Evolutionary histories of breast cancer and related clones
Autorzy:
Nishimura, TomomiAff1, Aff2, Aff3
Kakiuchi, NobuyukiAff1, Aff4, Aff5
Yoshida, KenichiAff1, Aff6
Sakurai, TakakiAff7, Aff8
Kataoka, Tatsuki R.Aff7, Aff9
Kondoh, EijiAff10, Aff11
Chigusa, Yoshitsugu
Kawai, Masahiko
Sawada, Morio
Inoue, Takuya
Takeuchi, YasuhideAff1, Aff7
Maeda, HironaAff1, Aff7
Baba, SatokoAff14, Aff15, Aff16
Shiozawa, Yusuke
Saiki, Ryunosuke
Nakagawa, Masahiro M.Aff1, Aff2
Nannya, YasuhitoAff1, Aff17
Ochi, Yotaro
Hirano, TomonoriAff1, Aff5, Aff18
Nakagawa, TomoeAff1, Aff18
Inagaki-Kawata, YukikoAff1, Aff3
Aoki, Kosuke
Hirata, Masahiro
Nanki, Kosaku
Matano, Mami
Saito, MegumuAff19, Aff20
Suzuki, EijiAff3, Aff21
Takada, Masahiro
Kawashima, Masahiro
Kawaguchi, Kosuke
Chiba, Kenichi
Shiraishi, Yuichi
Takita, Junko
Miyano, SatoruAff23, Aff24
Mandai, Masaki
Sato, Toshiro
Takeuchi, KengoAff14, Aff15, Aff16
Haga, Hironori
Toi, Masakazu
Ogawa, SeishiAff1, Aff18, Aff25, IDs41586023063339_cor40
Pokaż więcej
Źródło:
Nature: International weekly journal of science. 620(7974):607-614
Czasopismo naukowe
Szczegóły
Tytuł:
Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials
Autorzy:
Taylor, Carolyn
Dodwell, David
McGale, Paul
Hills, Robert K
Berry, Richard
Bradley, Rosie
Braybrooke, Jeremy
Clarke, Mike
Gray, Richard
Holt, Francesca
Liu, Zulian
Pan, Hongchao
Peto, Richard
Straiton, Ewan
Coles, Charlotte
Duane, Fran
Hennequin, Christophe
Jones, Glenn
Kühn, Thorsten
Oliveros, Sileida
Overgaard, Jens
Pritchard, Kathy I
Suh, Chang-Ok
Beake, Graham
Boddington, Clare
Davies, Christina
Davies, Lucy
Evans, Vaughan
Gay, Jo
Gettins, Lucy
Godwin, Jon
James, Sam
Kerr, Amanda
Liu, Hui
MacKinnon, Elizabeth
Mannu, Gurdeep
McHugh, Theresa
Morris, Philip
Nakahara, Mariko
Read, Simon
Taylor, Hannah
Ferguson, John
Scheurlen, Hans
Zurrida, Stefano
Galimberti, Viviana
Ingle, James
Valagussa, Pinuccia
Veronesi, Umberto
Anderson, Stewart
Tang, Gong
Fisher, Bernard
Fossa, Sophie
Valborg Reinertsen, Kristin
Host, Herman
Muss, Hyman
Holli, Kaija
Albain, Kathy
Arriagada, Rodrigo
Bartlett, John
Bergsten-Nordström, Elizabeth
Bliss, Judith
Brain, Etienne
Carey, Lisa
Coleman, Robert
Cuzick, Jack
Davidson, Nancy
Del Mastro, Lucia
Di Leo, Angelo
Dignam, James
Dowsett, Mitch
Ejlertsen, Bent
Francis, Prue
García-Sáenz, José Angel
Gelber, Rich
Gnant, Michael
Goetz, Matthew
Goodwin, Pam
Halpin-Murphy, Pat
Hayes, Dan
Hill, Catherine
Jagsi, Reshma
Janni, Wolfgang
Loibl, Sibylle
Mamounas, Eleftherios
Martín, Miguel
McIntosh, Stuart
Mukai, Hirofumi
Nekljudova, Valentina
Norton, Larry
Ohashi, Yasuo
Piccart, Martine
Pierce, Lori
Raina, Vinod
Rea, Daniel
Regan, Meredith
Robertson, John
Rutgers, Emiel
Salgado, Roberto
Slamon, Dennis
Spanic, Tanja
Sparano, Joseph
Steger, Guenther
Toi, Masakazu
Tutt, Andrew
Viale, Giuseppe
Wang, Xiang
Wilcken, Nicholas
Wolmark, Norman
Yu, Ke-Da
Cameron, David
Bergh, Jonas
Swain, Sandra
Whelan, Tim
Poortmans, Philip
Pokaż więcej
Źródło:
In The Lancet 25 November-1 December 2023 402(10416):1991-2003
Czasopismo naukowe
Szczegóły
Tytuł:
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)
Autorzy:
Kuo, Sung-HsinAff1, Aff2, Aff3, Aff4
Tseng, Ling-Ming
Chen, Shou-Tung
Sagara, Yasuaki
Chang, Yuan-Ching
Yeh, Hsien-Tang
Kuo, Yao-Lung
Hung, Chih-Chiang
Lu, Tzu-Pin
Lee, Yi-Hsuan
Toi, Masakazu
Huang, Chiun-ShengAff15, IDs12885023112916_cor12
Pokaż więcej
Źródło:
BMC Cancer. 23(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9
Autorzy:
Yamada, YosukeAff1, IDs12885023109495_cor1
Simon, Ronald
Iwane, Kosuke
Nakanishi, Yuki
Takeuchi, Yasuhide
Yoshizawa, Akihiko
Takada, Masahiro
Toi, Masakazu
Haga, Hironori
Marx, Alexander
Sauter, Guido
Pokaż więcej
Źródło:
BMC Cancer. 23(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Murine breast cancers disorganize the liver transcriptome in a zonated manner
Autorzy:
Vandenbon, AlexisAff1, Aff2, IDs4200302304479w_cor1
Mizuno, RinAff3, Aff4
Konishi, Riyo
Onishi, Masaya
Masuda, Kyoko
Kobayashi, Yuka
Kawamoto, Hiroshi
Suzuki, Ayako
He, ChenfengAff3, Aff7
Nakamura, YukiAff3, Aff7
Kawaguchi, Kosuke
Toi, Masakazu
Shimizu, Masahito
Tanaka, Yasuhito
Suzuki, YutakaAff5, IDs4200302304479w_cor15
Kawaoka, ShinpeiAff3, Aff10, IDs4200302304479w_cor16
Pokaż więcej
Źródło:
Communications Biology. 6(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial
Autorzy:
Yamauchi, HidekoAff1, Aff2, IDs12282023014518_cor1
Toi, MasakazuAff1, Aff3
Takayama, ShinAff1, Aff4
Nakamura, SeigoAff1, Aff5
Takano, ToshimiAff1, Aff6
Cui, Karen
Campbell, Christine
De Vos, Liesbet
Geyer, Jr, CharlesAff10, Aff11
Tutt, AndrewAff9, Aff12
Pokaż więcej
Źródło:
Breast Cancer. 30(4):596-605
Czasopismo naukowe
Szczegóły
Tytuł:
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)
Autorzy:
Imoto, ShigeruAff1, IDs12282023014367_cor1
Wang, Kun
Bi, Xi-wen
Liu, Guangyu
Im, Young-Hyuck
Im, Seock-Ah
Sim, Sung Hoon
Ueno, Takayuki
Futamura, Manabu
Toi, Masakazu
Fujiwara, Yasuhiro
Ahn, Sung Gwe
Lee, Jeong Eon
Park, Yeon Hee
Takao, Shintaro
Oba, Mari Saito
Kitagawa, Yuko
Nishiyama, Masahiko
Pokaż więcej
Źródło:
Breast Cancer. 30(3):412-423
Czasopismo naukowe
Szczegóły
Tytuł:
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials
Autorzy:
Braybrooke, Jeremy
Bradley, Rosie
Gray, Richard
Hills, Robert K
Pan, Hongchao
Peto, Richard
Dodwell, David
McGale, Paul
Taylor, Carolyn
Aihara, Tomohiko
Anderson, Stewart
Blum, Joanne
Cardoso, Fatima
Chen, Xiaosong
Crown, John P
Ejlertsen, Bent
Friedl, Thomas W P
Harbeck, Nadia
Janni, Wolfgang
Jensen, Maj-Britt
Mamounas, Eleftherios
Narui, Kazutaka
Nitz, Ulrike
Norton, Larry
O'Shaughnessy, Joyce
Piccart, Martine
Robert, Nicholas
Shao, Zhi-Ming
Slamon, Dennis
Sparano, Joseph
Watanabe, Toru
Yothers, Greg
Yu, Ke-Da
Berry, Richard
Boddington, Clare
Clarke, Mike
Davies, Christina
Davies, Lucy
Duane, Fran
Evans, Vaughan
Gay, Jo
Gettins, Lucy
Godwin, Jon
James, Sam
Lui, Hui
Lui, Zulian
MacKinnon, Elizabeth
Mannu, Gurdeep
McHugh, Theresa
Morris, Philip
Read, Simon
Straiton, Ewan
Buzdar, Aman
Suman, Vera J
Hunt, Kelly K
Leonard, Robert C F
Mansi, Janine
Delbaldo, Catherine
Piedbois, Pascal
Quinaux, Emmanuel
Fesl, Christian
Gnant, Michael
Sölkner, Lidija
Steger, Guenther
Eikesdal, Hans Petter
Lønning, Per Eystein
Bee, Valerie
Fung, Helena
Mackey, John
Martin, Miguel
Press, Michael
De Azambuja, Evandro
Gelber, Richard
Regan, Meredith
Di Leo, Angelo
Van Dooren, Veerle
Nogaret, Jean Marie
Bartlett, John
Chen, Bingshu E
Gelmon, Karen
Goss, Paul E
Levine, Mark N
Parulekar, Wendy
Pritchard, Kathleen I
Shepherd, Lois
Berry, Donald
Cirrincione, Constance
Shulman, Lawrence N
Winer, Eric
Gelman, Rebecca S
Harris, Jay R
Henderson, Craig
Shapiro, Charles L
Christiansen, Peer
Ewertz, Marianne
Mouridsen, Henning T
Van Leeuwen, Elise
Linn, Sabine
Van Rossum, Annelot G J
Van Tinteren, Harm
Van Werkhoven, Erik
Goldstein, Lori
Gray, Robert
Eiermann, Wolfgang
Gianni, Luca
Valagussa, Pinuccia
Bogaerts, Jan
Bonnefoi, Herve
Poncet, Coralie
Huovinen, Riikka
Joensuu, Heikki
Bonneterre, Jacques
Fargeot, Pierre
Fumoleau, Pierre
Kerbrat, Pierre
Luporsi, Elisabeth
Namer, Moïse
Carrasco, Eva M
Segui, Miguel Angel
Meisner, Christoph
Loibl, Sibylle
Nekljudova, Valentina
Thomssen, Christoph
Von Minckwitz, Gunter
Kümmel, Sherko
Lopez, Massimo
Vici, Patrizia
Fountzilas, George
Koliou, Georgia
Mavroudis, Dimitrios
Saloustros, Emmanouil
Brain, Etienne
Delaloge, Suzette
Michiels, Stefan
Mathoulin-Pelissier, Simone
Bines, Jose
Sarmento, Roberta M B
Bonadonna, Gianni
Brambilla, Cristina
Rossi, Anna
Bliss, Judith
Coombes, Raoul Charles
Kilburn, Lucy
Marty, Michel
Amadori, Dino
Boccardo, Francesco
Nanni, Oriana
Rubagotti, Alessandra
Scarpi, Emanuela
Masuda, Norikazu
Toi, Masakazu
Ueno, Takayuki
Ishikawa, Takashi
Matsumoto, Koji
Takao, Shintaro
Sommer, Harald
Foroglou, Pericles
Giokas, George
Kondylis, D
Lissaios, Byron
Reinisch, Mattea
Lee, Keun Seok
Nam, Byung-Ho
Ro, Jung Sil
De Matteis, Andrea
Perrone, Francesco
Tang, Gong
Wolmark, Norman
Hozumi, Yasuo
Nomura, Yasuo
Earl, Helena
Hiller, Louise
Vallier, Anne-Laure
De Mastro, Lucia
Venturini, Macro
Delozier, Thierry
Lemonnier, Jerome
Martin, Anne-Laure
Roché, Henri
Spielmann, Marc
Chen, Xiasong
Shen, Kunwei
Albain, Kathy
Barlow, William
Budd, George T
Gralow, Julie
Hayes, Dan
Bartlett-Lee, Peter
Ellis, Paul
Bianco, Angelo Raffaele
De Laurentiis, Michelino
De Placido, Sabino
Wildiers, Hans
Hsu, Limin
Eremin, Oleg
Walker, Leslie G
Ahlgren, Johan
Blomqvist, Carl
Holmberg, Lars
Lindman, Henrik
Asmar, Lina
Jones, Stephen E
Gluz, Oleg
Liedtke, Cornelia
Arriagada, Rodrigo
Bergsten-Nordström, Elizabeth
Carey, Lisa
Coleman, Robert
Cuzick, Jack
Davidson, Nancy
Dignam, James
Dowsett, Mitch
Francis, Prudence A
Goetz, Matthew P
Goodwin, Pam
Halpin-Murphy, Pat
Hill, Catherine
Jagsi, Reshma
Mukai, Hirofumi
Ohashi, Yasuo
Pierce, Lori
Poortmans, Philip
Raina, Vinod
Rea, Daniel
Robertson, John
Rutgers, Emiel
Salgado, Roberto
Spanic, Tanja
Tutt, Andrew
Viale, Giuseppe
Wang, Xiang
Whelan, Tim
Wilcken, Nicholas
Cameron, David
Bergh, Jonas
Swain, Sandra M
Pokaż więcej
Źródło:
In The Lancet 15-21 April 2023 401(10384):1277-1292
Czasopismo naukowe
Szczegóły
Tytuł:
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
Autorzy:
Johnston, Stephen R D
Toi, Masakazu
O'Shaughnessy, Joyce
Rastogi, Priya
Campone, Mario
Neven, Patrick
Huang, Chiun-Sheng
Huober, Jens
Jaliffe, Georgina Garnica
Cicin, Irfan
Tolaney, Sara M
Goetz, Matthew P
Rugo, Hope S
Senkus, Elzbieta
Testa, Laura
Del Mastro, Lucia
Shimizu, Chikako
Wei, Ran
Shahir, Ashwin
Munoz, Maria
San Antonio, Belen
André, Valérie
Harbeck, Nadia
Martin, Miguel
Pokaż więcej
Źródło:
In The Lancet Oncology January 2023 24(1):77-90
Czasopismo naukowe
Szczegóły
Tytuł:
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial
Autorzy:
Saji, Shigehira
Taira, Naruto
Kitada, Masahiro
Takano, Toshimi
Takada, Masahiro
Ohtake, Tohru
Toyama, Tatsuya
Kikawa, Yuichiro
Hasegawa, Yoshie
Fujisawa, Tomomi
Kashiwaba, Masahiro
Ishida, Takanori
Nakamura, Rikiya
Yamamoto, Yutaka
Toh, Uhi
Iwata, Hiroji
Masuda, Norikazu
Morita, Satoshi
Ohno, Shinji
Toi, Masakazu
Pokaż więcej
Źródło:
In The Lancet Oncology May 2022 23(5):636-649
Czasopismo naukowe
Szczegóły
Tytuł:
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies
Autorzy:
Yamamoto, YutakaAff1, IDs12282022013991_cor1
Yamashiro, Hiroyasu
Schneeweiss, Andreas
Müller, Volkmar
Gluz, Oleg
Klare, Peter
Aktas, BahriyeAff7, Aff8
Magdolna, Dank
Büdi, László
Pikó, Béla
Mangel, László
Toi, Masakazu
Morita, Satoshi
Ohno, Shinji
Pokaż więcej
Źródło:
Breast Cancer. 30(1):88-100
Czasopismo naukowe
Szczegóły
Tytuł:
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
Autorzy:
Bradley, Rosie
Braybrooke, Jeremy
Gray, Richard
Hills, Robert K
Liu, Zulian
Pan, Hongchao
Peto, Richard
Dodwell, David
McGale, Paul
Taylor, Carolyn
Francis, Prudence A
Gnant, Michael
Perrone, Francesco
Regan, Meredith M
Berry, Richard
Boddington, Clare
Clarke, Mike
Davies, Christina
Davies, Lucy
Duane, Fran
Evans, Vaughan
Gay, Jo
Gettins, Lucy
Godwin, Jon
James, Sam
Liu, Hui
MacKinnon, Elizabeth
Mannu, Gurdeep
McHugh, Theresa
Morris, Philip
Read, Simon
Straiton, Ewan
Jakesz, Raimund
Fesl, Christian
Pagani, Olivia
Gelber, Richard
De Laurentiis, Michelino
De Placido, Sabino
Gallo, Ciro
Albain, Kathy
Anderson, Stewart
Arriagada, Rodrigo
Bartlett, John
Bergsten-Nordström, Elizabeth
Bliss, Judith
Brain, Etienne
Carey, Lisa
Coleman, Robert
Cuzick, Jack
Davidson, Nancy
Del Mastro, Lucia
Di Leo, Angelo
Dignam, James
Dowsett, Mitch
Ejlertsen, Bent
Goetz, Matthew
Goodwin, Pam
Halpin-Murphy, Pat
Hayes, Dan
Hill, Catherine
Jagsi, Reshma
Janni, Wolfgang
Loibl, Sibylle
Mamounas, Eleftherios P
Martín, Miguel
Mukai, Hirofumi
Nekljudova, Valentina
Norton, Larry
Ohashi, Yasuo
Pierce, Lori
Poortmans, Philip
Pritchard, Kathleen I
Raina, Vinod
Rea, Daniel
Robertson, John
Rutgers, Emiel
Spanic, Tanja
Sparano, Joseph
Steger, Guenther
Tang, Gong
Toi, Masakazu
Tutt, Andrew
Viale, Giuseppe
Wang, Xiang
Whelan, Tim
Wilcken, Nicholas
Wolmark, Norman
Cameron, David
Bergh, Jonas
Swain, Sandra M
Pokaż więcej
Źródło:
In The Lancet Oncology March 2022 23(3):382-392
Czasopismo naukowe
Szczegóły
Tytuł:
Effectiveness of eribulin as first-line or second-line chemotherapy for HER2-negative hormone-resistant advanced or metastatic breast cancer: findings from the multi-institutional, prospective, observational KBCRN A001: E-SPEC study
Autorzy:
Kikawa, YuichiroAff1, Aff2, IDs1228202201357x_cor1
Kotake, TakeshiAff3, Aff4
Tsuyuki, Shigeru
Kang, Yookija
Takahara, Sachiko
Fujimoto, Yuri
Yamashiro, Hiroyasu
Yoshibayashi, Hiroshi
Takada, Masahiro
Yasuoka, Rie
Nakatsukasa, Katsuhiko
Yamagami, Kazuhiko
Suwa, Hirofumi
Okuno, Toshitaka
Nakayama, Ichiro
Kato, Tatsushi
Ogura, Nobuko
Moriguchi, Yoshio
Ishiguro, Hiroshi
Kagimura, Tatsuo
Taguchi, Tetsuya
Sugie, Tomoharu
Toi, Masakazu
Pokaż więcej
Źródło:
Breast Cancer. 29(5):796-807
Czasopismo naukowe
Szczegóły
Tytuł:
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
Autorzy:
Bradley, Rosie
Braybrooke, Jeremy
Gray, Richard
Hills, Robert
Liu, Zulian
Peto, Richard
Davies, Lucy
Dodwell, David
McGale, Paul
Pan, Hongchao
Taylor, Carolyn
Anderson, Stewart
Gelber, Richard
Gianni, Luca
Jacot, William
Joensuu, Heikki
Moreno-Aspitia, Alvaro
Piccart, Martine
Press, Michael
Romond, Edward
Slamon, Dennis
Suman, Vera
Berry, Richard
Boddington, Clare
Clarke, Mike
Davies, Christina
Duane, Fran
Evans, Vaughan
Gay, Jo
Gettins, Lucy
Godwin, Jon
James, Sam
Liu, Hui
MacKinnon, Elizabeth
Mannu, Gurdeep
McHugh, Theresa
Morris, Philip
Read, Simon
Straiton, Ewan
Wang, Yaochen
Crown, John
de Azambuja, Evandro
Delaloge, Suzette
Fung, Helena
Geyer, Charles
Spielmann, Marc
Valagussa, Pinuccia
Albain, Kathy
Arriagada, Rodrigo
Bartlett, John
Bergsten-Nordström, Elizabeth
Bliss, Judith
Brain, Etienne
Carey, Lisa
Coleman, Robert
Cuzick, Jack
Davidson, Nancy
Del Mastro, Lucia
Di Leo, Angelo
Dignam, James
Dowsett, Mitch
Ejlertsen, Bent
Francis, Prue
Gnant, Michael
Goetz, Matthew
Goodwin, Pam
Halpin-Murphy, Pat
Hayes, Dan
Hill, Catherine
Jagsi, Reshma
Janni, Wolfgang
Loibl, Sibylle
Mamounas, Eleftherios P
Martín, Miguel
Mukai, Hirofumi
Nekljudova, Valentina
Norton, Larry
Ohashi, Yasuo
Pierce, Lori
Poortmans, Philip
Raina, Vinod
Rea, Daniel
Regan, Meredith
Robertson, John
Rutgers, Emiel
Spanic, Tanja
Sparano, Joseph
Steger, Guenther
Tang, Gong
Toi, Masakazu
Tutt, Andrew
Viale, Giuseppe
Wang, Xiang
Whelan, Tim
Wilcken, Nicholas
Wolmark, Norman
Cameron, David
Bergh, Jonas
Pritchard, Kathleen I
Swain, Sandra M
Pokaż więcej
Źródło:
In The Lancet Oncology August 2021 22(8):1139-1150
Czasopismo naukowe
Szczegóły
Tytuł:
Correction: Adjuvant olaparib in the subset of patients from Japan with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial
Autorzy:
Yamauchi, HidekoAff1, Aff2, IDs1228202301468z_cor1
Toi, MasakazuAff1, Aff3
Takayama, ShinAff1, Aff4
Nakamura, SeigoAff1, Aff5
Takano, ToshimiAff1, Aff6
Cui, Karen
Campbell, Christine
De Vos, Liesbet
Geyer, Jr, CharlesAff10, Aff11
Tutt, AndrewAff9, Aff12
Pokaż więcej
Źródło:
Breast Cancer. 30(4):606-606
Czasopismo naukowe
Szczegóły
Tytuł:
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR
Autorzy:
Ueno, TakayukiAff1, Aff2, IDs12916022023321_cor1
Kitano, Shigehisa
Masuda, Norikazu
Ikarashi, Daiki
Yamashita, Makiko
Chiba, Tomohiro
Kadoya, Takayuki
Bando, Hiroko
Yamanaka, Takashi
Ohtani, Shoichiro
Nagai, Shigenori
Nakayama, Takahiro
Takahashi, Masato
Saji, Shigehira
Aogi, Kenjiro
Velaga, Ravi
Kawaguchi, Kosuke
Morita, Satoshi
Haga, Hironori
Ohno, Shinji
Toi, Masakazu
Pokaż więcej
Źródło:
BMC Medicine. 20(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Phase Ib/II study of nivolumab combined with palliative radiation therapy for bone metastasis in patients with HER2-negative metastatic breast cancer
Autorzy:
Takada, MasahiroAff1, IDs41598022270483_cor1
Yoshimura, Michio
Kotake, Takeshi
Kawaguchi, Kosuke
Uozumi, Ryuji
Kataoka, Masako
Kato, Hironori
Yoshibayashi, Hiroshi
Suwa, Hirofumi
Tsuji, Wakako
Yamashiro, Hiroyasu
Suzuki, Eiji
Torii, Masae
Yamada, Yosuke
Kataoka, Tatsuki
Ishiguro, Hiroshi
Morita, Satoshi
Toi, Masakazu
Pokaż więcej
Źródło:
Scientific Reports. 12(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Trends in adjuvant therapy after breast-conserving surgery for ductal carcinoma in situ of breast: a retrospective cohort study using the National Breast Cancer Registry of Japan
Autorzy:
Yotsumoto, Daisuke
Sagara, YasuakiAff2, IDs1228202101307z_cor2
Kumamaru, Hiraku
Niikura, Naoki
Miyata, Hiroaki
Kanbayashi, Chizuko
Tsuda, Hitoshi
Yamamoto, Yutaka
Aogi, Kenjiro
Kubo, Makoto
Tamura, Kenji
Hayashi, Naoki
Miyashita, Minoru
Kadoya, Takayuki
Saji, Shigehira
Toi, Masakazu
Imoto, Shigeru
Jinno, Hiromitsu
Pokaż więcej
Źródło:
Breast Cancer. 29(1):1-8
Czasopismo naukowe
Szczegóły
Tytuł:
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
Autorzy:
Takahashi, Masato
Tokunaga, Eriko
Mori, Joji
Tanizawa, Yoshinori
van der Walt, Jan-Stefan
Kawaguchi, Tsutomu
Goetz, Matthew P.
Toi, MasakazuAff6, IDs12282021012950_cor8
Pokaż więcej
Źródło:
Breast Cancer. 29(1):174-184
Czasopismo naukowe
Szczegóły
Tytuł:
Palbociclib as an early-line treatment for Japanese patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: a review of clinical trial and real-world data
Autorzy:
Masuda, NorikazuAff1, IDs10147021020138_cor1
Kosaka, Nobuyoshi
Iwata, Hiroji
Toi, Masakazu
Pokaż więcej
Źródło:
International Journal of Clinical Oncology. 26(12):2179-2193
Czasopismo naukowe
Szczegóły
Tytuł:
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17)
Autorzy:
Fukada, Ippei
Ito, Yoshinori
Kondo, Naoto
Ohtani, Shoichiro
Hattori, Masaya
Tokunaga, Eriko
Matsunami, NobukiAff6, Aff7
Mashino, Kohjiro
Kosaka, TaijiroAff9, Aff10
Tanabe, MasahikoAff11, Aff12
Yotsumoto, Daisuke
Yamanouchi, Kosho
Sawaki, Masataka
Kashiwaba, MasahiroAff15, Aff16
Kawabata, Hidetaka
Kuroi, KatsumasaAff18, Aff19
Morita, Satoshi
Ohno, Shinji
Toi, Masakazu
Masuda, Norikazu
Pokaż więcej
Źródło:
Breast Cancer Research and Treatment. 190(3):425-434
Czasopismo naukowe
Szczegóły
Tytuł:
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy
Autorzy:
Inoue, Kenichi
Masuda, Norikazu
Iwata, Hiroji
Takahashi, Masato
Ito, Yoshinori
Miyoshi, Yasuo
Nakayama, Takahiro
Mukai, Hirofumi
van der Walt, Jan-Stefan
Mori, Joji
Sakaguchi, Sachi
Kawaguchi, Tsutomu
Tanizawa, Yoshinori
Llombart-Cussac, AntonioAff11, Aff12
Sledge, Jr, George W.
Toi, Masakazu
Pokaż więcej
Źródło:
Breast Cancer. 28(5):1038-1050
Czasopismo naukowe
Szczegóły
Tytuł:
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
Autorzy:
Aogi, KenjiroAff1, IDs10147022022372_cor1
Watanabe, Kenichi
Kitada, Masahiro
Sangai, Takafumi
Ohtani, Shoichiro
Aruga, Tomoyuki
Kawaguchi, Hidetoshi
Fujisawa, Tomomi
Maeda, Shigeto
Morimoto, Takashi
Sato, Nobuaki
Takao, Shintaro
Morita, Satoshi
Masuda, Norikazu
Toi, Masakazu
Ohno, Shinji
Pokaż więcej
Źródło:
International Journal of Clinical Oncology. 27(11):1793-1793
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)
Autorzy:
Aogi, KenjiroAff1, IDs10147021019200_cor1
Watanabe, Kenichi
Kitada, Masahiro
Sangai, Takafumi
Ohtani, Shoichiro
Aruga, Tomoyuki
Kawaguchi, Hidetoshi
Fujisawa, Tomomi
Maeda, Shigeto
Morimoto, Takashi
Sato, Nobuaki
Takao, Shintaro
Morita, Satoshi
Masuda, Norikazu
Toi, Masakazu
Ohno, Shinji
Pokaż więcej
Źródło:
International Journal of Clinical Oncology. 26(7):1229-1236
Czasopismo naukowe
Szczegóły
Tytuł:
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial
Autorzy:
Masuda, Norikazu
Bando, Hiroko
Yamanaka, Takashi
Kadoya, Takayuki
Takahashi, Masato
Nagai, Shigenori E.
Ohtani, Shoichiro
Aruga, Tomoyuki
Suzuki, Eiji
Kikawa, Yuichiro
Yasojima, Hiroyuki
Kasai, Hiroi
Ishiguro, Hiroshi
Kawabata, Hidetaka
Morita, Satoshi
Haga, Hironori
Kataoka, Tatsuki R.
Uozumi, Ryuji
Ohno, Shinji
Toi, Masakazu
Pokaż więcej
Źródło:
Breast Cancer Research and Treatment. 188(1):117-131
Czasopismo naukowe
Szczegóły
Tytuł:
Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials
Autorzy:
Goetz, Matthew P.
Okera, Meena
Wildiers, Hans
Campone, Mario
Grischke, Eva-Maria
Manso, Luis
André, Valérie A. M.
Chouaki, Nadia
San Antonio, Belén
Toi, Masakazu
Sledge, Jr., George W.
Pokaż więcej
Źródło:
Breast Cancer Research and Treatment. 186(2):417-428
Czasopismo naukowe
Szczegóły
Tytuł:
Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3
Autorzy:
Masuda, Norikazu
Mukai, Hirofumi
Inoue, Kenichi
Rai, Yoshiaki
Ohno, Shinji
Ohtani, Shoichiro
Shimizu, Chikako
Hashigaki, Satoshi
Muramatsu, Yasuaki
Umeyama, Yoshiko
Iwata, Hiroji
Toi, Masakazu
Pokaż więcej
Źródło:
Breast Cancer. 28(2):335-345
Czasopismo naukowe
Szczegóły
Tytuł:
Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2–positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study)
Autorzy:
Yamashita, Toshinari
Kawaguchi, Hidetoshi
Masuda, Norikazu
Kitada, Masahiro
Narui, Kazutaka
Hattori, Masaya
Yoshinami, Tetsuhiro
Matsunami, Nobuki
Yanagihara, Kazuhiro
Kawasoe, Teru
Nagashima, Takeshi
Bando, Hiroko
Yano, Hiroshi
Hasegawa, Yoshie
Nakamura, Rikiya
Kashiwaba, Masahiro
Morita, Satoshi
Ohno, Shinji
Toi, Masakazu
Pokaż więcej
Źródło:
Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies. 39(1):217-225
Czasopismo naukowe
Szczegóły
Tytuł:
Vascular branching point counts using photoacoustic imaging in the superficial layer of the breast: A potential biomarker for breast cancer
Autorzy:
Yamaga, Iku
Kawaguchi-Sakita, Nobuko
Asao, Yasufumi
Matsumoto, Yoshiaki
Yoshikawa, Aya
Fukui, Toshifumi
Takada, Masahiro
Kataoka, Masako
Kawashima, Masahiro
Fakhrejahani, Elham
Kanao, Shotaro
Nakayama, Yoshie
Tokiwa, Mariko
Torii, Masae
Yagi, Takayuki
Sakurai, Takaki
Haga, Hironori
Togashi, Kaori
Shiina, Tsuyoshi
Toi, Masakazu
Pokaż więcej
Źródło:
In Photoacoustics September 2018 11:6-13
Czasopismo naukowe
Szczegóły
Tytuł:
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study
Autorzy:
Yamaguchi, Ayane
Honda, Maya
Ishiguro, Hiroshi
Kataoka, Masako
Kataoka, Tatsuki R.
Shimizu, Hanako
Torii, Masae
Mori, Yukiko
Kawaguchi-Sakita, Nobuko
Ueno, Kentaro
Kawashima, Masahiro
Takada, Masahiro
Suzuki, Eiji
Nakamoto, Yuji
Kawaguchi, Kosuke
Toi, Masakazu
Pokaż więcej
Źródło:
Scientific Reports. 11(1)
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study
Autorzy:
Yamamoto, Yutaka
Yamashiro, Hiroyasu
Toh, Uhi
Kondo, NaotoAff4, Aff5
Nakamura, Rikiya
Kashiwaba, Masahiro
Takahashi, Masato
Tsugawa, Koichiro
Ishikawa, Takashi
Nakayama, Takahiro
Ohtani, Shoichiro
Takano, Toshimi
Fujisawa, Tomomi
Toyama, Tatsuya
Kawaguchi, Hidetoshi
Mashino, Kojiro
Tanino, Yuichi
Morita, Satoshi
Toi, Masakazu
Ohno, Shinji
Pokaż więcej
Źródło:
Breast Cancer. 28(1):145-160
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
Autorzy:
Ueno, Takayuki
Saji, Shigehira
Masuda, Norikazu
Kuroi, Katsumasa
Sato, Nobuaki
Takei, Hiroyuki
Yamamoto, Yutaka
Ohno, Shinji
Yamashita, Hiroko
Hisamatsu, Kazufumi
Aogi, Kenjiro
Iwata, Hiroji
Yamanaka, Takeharu
Sasano, Hironobu
Toi, Masakazu
Pokaż więcej
Źródło:
In ESMO Open 2018 3(2)
Czasopismo naukowe
Szczegóły
Tytuł:
Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study
Autorzy:
Kawaguchi, Hidetoshi
Masuda, Norikazu
Nakayama, Takahiro
Aogi, Kenjiro
Anan, Keisei
Ito, Yoshinori
Ohtani, Shoichiro
Sato, Nobuaki
Saji, Shigehira
Takano, Toshimi
Tokunaga, Eriko
Nakamura, Seigo
Hasegawa, Yoshie
Hattori, Masaya
Fujisawa, Tomomi
Morita, Satoshi
Yamaguchi, Miki
Yamashita, Hiroko
Yamashita, Toshinari
Yamamoto, Yutaka
Yotsumoto, Daisuke
Toi, Masakazu
Ohno, Shinji
Pokaż więcej
Źródło:
Breast Cancer. 27(3):389-398
Czasopismo naukowe
Szczegóły
Tytuł:
A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer
Autorzy:
Ishiguro, Hiroshi
Masuda, Norikazu
Sato, Nobuaki
Higaki, Kenji
Morimoto, Takashi
Yanagita, Yasuhiro
Mizutani, Makiko
Ohtani, Shoichiro
Kaneko, Koji
Fujisawa, Tomomi
Takahashi, Masato
Kadoya, Takayuki
Matsunami, Nobuki
Yamamoto, Yutaka
Ohno, Shinji
Takano, Toshimi
Morita, Satoshi
Tanaka-Mizuno, SachikoAff14, Aff15
Toi, Masakazu
Pokaż więcej
Źródło:
Breast Cancer Research and Treatment. 180(3):715-724
Czasopismo naukowe
Szczegóły
Tytuł:
A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer
Autorzy:
Masuda, Norikazu
Ohtani, Shoichiro
Takano, Toshimi
Inoue, Kenichi
Suzuki, Eiji
Nakamura, Rikiya
Bando, Hiroko
Ito, Yoshinori
Ishida, Kazushige
Yamanaka, Takashi
Kuroi, Katsumasa
Yasojima, Hiroyuki
Kasai, Hiroi
Takasuka, Tsuyoshi
Sakurai, Takaki
Kataoka, Tatsuki R.
Morita, Satoshi
Ohno, Shinji
Toi, Masakazu
Pokaż więcej
Źródło:
Breast Cancer Research and Treatment. 180(1):135-146
Czasopismo naukowe
Szczegóły
Tytuł:
A snapshot of surgical resident training in Japan: results of a national-level needs assessment survey
Autorzy:
Poudel, Saseem
Hirano, Satoshi
Kurashima, Yo
Stefanidis, Dimitrios
Akiyama, Hirotoshi
Eguchi, Susumu
Fukui, Toshihiro
Hagiwara, Masaru
Hashimoto, Daisuke
Hida, Koya
Izaki, Tomoko
Iwase, Hirotaka
Kawamoto, Shunsuke
Otomo, Yasuhiro
Nagai, Eishi
Saito, Mitsue
Takami, Hideki
Takeda, Yuko
Toi, Masakazu
Yamaue, Hiroki
Yoshida, Motofumi
Yoshida, Shigetoshi
Kodera, Yasuhiro
Pokaż więcej
Źródło:
Surgery Today: Official Journal of the Japan Surgical Society. 49(10):870-876
Czasopismo naukowe
Szczegóły
Tytuł:
Pharmacogenomic–pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer
Autorzy:
Ishiguro, HiroshiAff1, Aff14
Ohno, ShinjiAff2, Aff14
Yamamoto, YutakaAff3, Aff14
Takao, ShintaroAff4, Aff14
Sato, NobuakiAff5, Aff14
Fujisawa, TomomiAff6, Aff14
Kadoya, TakayukiAff7, Aff14
Kuroi, KatsumasaAff8, Aff14
Bando, HirokoAff9, Aff14
Teramura, YasufumiAff10, Aff14
Iwata, HirojiAff11, Aff14
Tanaka, Shiro
Toi, MasakazuAff13, Aff14
Pokaż więcej
Źródło:
Breast Cancer. 26(5):535-543
Czasopismo naukowe
Szczegóły
Tytuł:
A New Concept for Axillary Treatment of Primary Breast Cancer Using Indocyanine Green Fluorescence Imaging
Autorzy:
Takada, Masahiro
Toi, Masakazu
Pokaż więcej
Źródło:
ICG Fluorescence Imaging and Navigation Surgery. :139-147
Książka elektroniczna
Szczegóły
Tytuł:
Disruption of hypoxia-inducible fatty acid binding protein 7 induces beige fat-like differentiation and thermogenesis in breast cancer cells
Autorzy:
Kawashima, MasahiroAff1, Aff5, IDs40170020002194_cor1
Bensaad, Karim
Zois, Christos E.
Barberis, Alessandro
Bridges, Esther
Wigfield, Simon
Lagerholm, Christoffer
Dmitriev, Ruslan I.Aff4, Aff6
Tokiwa, Mariko
Toi, Masakazu
Papkovsky, Dmitri B.
Buffa, Francesca M.
Harris, Adrian L.
Pokaż więcej
Źródło:
Cancer & Metabolism. 8(1)
Czasopismo naukowe
Szczegóły
Tytuł:
Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
Autorzy:
Hurvitz, Sara A
Andre, Fabrice
Jiang, Zefei
Shao, Zhimin
Mano, Max S
Neciosup, Silvia P
Tseng, Ling-Min
Zhang, Qingyuan
Shen, Kunwei
Liu, Donggeng
Dreosti, Lydia M
Burris, Howard A
Toi, Masakazu
Buyse, Marc E
Cabaribere, David
Lindsay, Mary-Ann
Rao, Shantha
Pacaud, Lida Bubuteishvili
Taran, Tetiana
Slamon, Dennis
Pokaż więcej
Źródło:
In The Lancet Oncology July 2015 16(7):816-829
Czasopismo naukowe
Szczegóły
Tytuł:
Palbociclib in combination with letrozole in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients
Autorzy:
Mukai, Hirofumi
Shimizu, Chikako
Masuda, Norikazu
Ohtani, Shoichiro
Ohno, Shinji
Takahashi, Masato
Yamamoto, Yutaka
Nishimura, Reiki
Sato, Nobuaki
Ohsumi, Shozo
Iwata, Hiroji
Mori, Yuko
Hashigaki, Satoshi
Muramatsu, Yasuaki
Nagasawa, Takashi
Umeyama, Yoshiko
Lu, Dongrui R.
Toi, Masakazu
Pokaż więcej
Źródło:
International Journal of Clinical Oncology. 24(3):274-287
Czasopismo naukowe
Szczegóły
Tytuł:
Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm
Autorzy:
Takada, Masahiro
Sugimoto, Masahiro
Masuda, Norikazu
Iwata, Hiroji
Kuroi, Katsumasa
Yamashiro, Hiroyasu
Ohno, Shinji
Ishiguro, Hiroshi
Inamoto, Takashi
Toi, Masakazu
Pokaż więcej
Źródło:
Breast Cancer Research and Treatment. 172(3):611-618
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-100 z 1000

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies